CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone [Phase 2]
Summary
Phase 2 trial evaluating dasatinib in patients with stage IV breast cancer that has spread to the bone has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02